If you are a food ingredient company struggling to source enough high-quality alginate or seaweed extracts — this project developed a total-utilisation refining process that produces 12 products from a single seaweed species versus the industry average of 1-2. With letters of intent already signed by large customers, this technology addresses the market scarcity of pure, chemical-free seaweed products.
Zero-Waste Seaweed Processing That Turns 100% of Raw Material Into 12 Sellable Products
Imagine buying a whole fish but only eating 15% and throwing the rest away — that's how the seaweed industry works today. Alginor built a technology that uses virtually everything from harvested kelp, turning one raw material into 12 different products instead of the usual one or two. On top of that, the old way of processing creates serious pollution, which has led to strict production limits. Alginor's method eliminates those emissions entirely, meaning they can massively scale up production from Europe's enormous untapped kelp forests.
What needed solving
The global seaweed products market suffers from chronic supply shortages because current processing technology wastes 85% of every harvested kelp plant and pollutes the environment in the process. These emissions have triggered strict regulations that cap production volumes — in Norway, only 150,000 tonnes are harvested annually despite 1.5 million tonnes being sustainably available. Companies that need high-quality alginates, seaweed extracts, and marine bioactives simply cannot get enough supply.
What was built
Alginor developed and validated the AORTA refining technology — a zero-emission seaweed processing system that extracts up to 12 distinct products from Laminaria hyperborea kelp, using nearly 100% of the harvested biomass. Deliverables included a verified minimum viable product (MVP) and a verified full production process (FPP) assessment.
Who needs this
Who can put this to work
If you are a cosmetics manufacturer looking for sustainable, toxin-free marine-derived ingredients — this project built a zero-emission processing line that extracts multiple high-purity compounds from Laminaria hyperborea kelp. Current industry utilises only 15% of harvested biomass, but this technology pushes toward 100%, opening up a wider range of bioactive ingredients at higher quality.
If you are a biorefinery operator dealing with low yields and emission-related production caps — this project demonstrated a refining technology that eliminates the pollution that currently limits harvesting to 150,000 tonnes per year out of 1.5 million tonnes available. Moving from 15% to near-100% resource efficiency means dramatically more output per tonne of raw seaweed processed.
Quick answers
What would it cost to license or adopt this technology?
The project data does not include specific licensing fees or technology transfer pricing. Alginor is a commercial SME that developed this technology for its own production operations. Any licensing or partnership terms would need to be discussed directly with Alginor.
Can this work at industrial scale?
The technology was designed for industrial-scale production from the start. Alginor projects annual turnover of €16.5 million within 3 years of launch, with over 165 jobs. Europe has a standing biomass of approximately 100 million tonnes of Laminaria hyperborea, with at least 1.5 million tonnes available for annual harvest — far exceeding the current 150,000 tonnes harvested industry-wide.
What is the intellectual property situation?
Alginor developed this as a proprietary technology called AORTA. As an SME-funded project under the EU's SME Instrument Phase 2, IP typically stays with the company. Based on available project data, specific patent details are not disclosed.
How does this meet environmental regulations?
The technology eliminates the emissions that plague current seaweed processing. In Norway, increasing concern over pollution from the seaweed industry has led to production limitations. Alginor's process has no such emissions, removing these regulatory constraints entirely and enabling higher production volumes.
What is the project timeline and current status?
The project ran from September 2018 to December 2020 and is now closed. Deliverables included verified MVP and FPP (full production process) value assessments. Letters of intent were signed with several large customers during the project.
What products come out of this process?
The AORTA technology creates a portfolio of 12 products from a single seaweed species, compared to the industry average of 1-2 products. The project states these products will be of equal or higher quality than existing alternatives, produced without toxic chemicals.
Is there customer validation?
Yes. Letters of intent were signed with several large customers before the project concluded. The company projected a return on capital employed of 37.6%, suggesting strong market confidence in the product lineup.
Who built it
This is a single-company project — Alginor ASA from Norway, a verified SME operating as a private commercial entity. With 100% industry participation and no university or research partners, the consortium signals a commercially driven venture rather than a research exercise. The SME Instrument Phase 2 funding confirms this is a company with a validated business concept seeking to scale its technology toward market deployment. For a potential business partner, this means you would be dealing directly with the technology owner and future producer, not navigating a multi-party academic consortium.
- ALGINOR ASACoordinator · NO
Alginor ASA is a Norwegian SME — contact details can be found through their company website at alginor.no
Talk to the team behind this work.
Want an introduction to Alginor's team to discuss supply partnerships, licensing, or ingredient sourcing? SciTransfer can arrange a direct meeting — contact us for matchmaking.